Tagged with manufacturing

Europe The latest EFPIA data ranking European countries by the value of their pharmaceutical production. Switzerland is far and away the leader by this measurement, with EUR 46.280 billion-worth of pharma production in 2016, followed by Italy and Germany.

Turkey Philipp Haas, chairman and CEO of DEVA, discusses the company’s export strategy and current positioning in the international pharmaceutical playing field. Haas also covers the changing dynamics of the industry in the Turkish market. In crisis there is opportunity for those who are willing to take it 2018 has been…

Turkey Turgut Tokgöz, secretary general of the Pharmaceutical Manufacturers Association of Turkey (IEIS), provides his take on the state of the Turkish pharmaceutical sector, highlighting the challenges that the industry faces with domestic pricing policy, the currency crisis of the Turkish Lira, and the barriers hindering Turkish firms from entering the…

Algeria A sudden imposition of import restrictions on pharmaceuticals in 2017 has pushed several multinational companies to establish local production facilities in Algeria. However, the localization process can be fraught both for companies that establish direct manufacturing footprints via joint ventures and those that employ the services of local contract manufacturers.…

Turkey Dr Orhan Mutlu Topal, general manager at Emre Ecza Ilac, offers an insider take on the Turkish vaccine industry, the challenges on the horizon for the Turkish pharmaceutical sector, and the country’s technology transfer from localization policies. The localization of vaccine production will be a groundbreaking achievement for Turkey. This is…

Malaysia Saravanan G., group managing director of Biocare Group, details the opportunities he identified to create the first MDI (Metered Dose Inhalers) manufacturing plant in Malaysia. He also explains further the support received by the government for his initiatives and how the company will continue its efforts to bring more innovative…

Korea According to data from the Ministry of Health and Welfare, South Korea’s exports of products in the healthcare sector surged 30.9 percent in the first half from last year. Exports of drugs, medical devices, and cosmetics amounted to $7.1 billion (7.8 trillion won) in the first half, up almost 31 percent…

Malaysia Javed Ghulam, CEO of AJ Research & Pharma, offers insights into the dynamic pharma industry in Malaysia and what it takes to be a competitive player in the region.   Being part of AJ Pharmaceuticals Holdings, what is the scope of operations specific to AJ Research & Pharma? AJ Research…

Algeria Guillaume Seillier, general director of Servier Algeria discusses recent changes in the affiliate, localization strategies, and Algeria’s importance to Servier’s regional and global operations.   We would like to reach 100 percent local production by 2020 Could you introduce the current face of Servier and the main changes and emerging…

Algeria Haissam Chraiteh, country chair for Sanofi Algeria, expands on Sanofi’s ground-breaking foothold in Algerian local production, and how its partnership with the authorities ultimately manifests itself in better provision for patients.   What are your impressions of the Algerian market after two years here as country chair for Sanofi Algeria?…

France Key statistics on the workforce, revenue, investment levels, R&D spending and consumption in the French pharmaceutical industry today. Mapping the 32 biopharma production sites in France, including the location, company and products produced. France ranks fourth in the EU for pharma production with EUR 20.981 billion in value, behind Switzerland,…

Algeria Mourad Ishak, country president Novartis and general manager Sandoz Algeria reveals Novartis’ investment plan for local production, their “under one roof” project for the Novartis entities, and the key strategies to ensure sustainability within the Algerian market.   You’ve been in Algeria for four years. Can you enlighten our viewers…